Shedding light on industry influence over healthcare
New study maps ties between the medical product industry and healthcare ecosystem, exposing regulatory and transparency issues.
What are the potential applications of social media and altmetrics in the pharmaceutical industry?
How can pharma unlock the potential of social media? A recent article from EMWA’s Medical Writing journal discusses potential applications.
WHO and ICMRA announce a joint statement on data transparency and integrity
Read about their call to action for the pharmaceutical industry to increase sharing of clinical trial data.
How can the healthcare industry embrace the rise of social media video content?
Creators of Industry Voice share tips on how to leverage video content to generate discussion among experts, engage viewers, and build brand value.
Opportunities and challenges in open access publishing of industry-sponsored research
Medical Publishing Insights and Practices (MPIP) initiative members share perspectives on the benefits of publishing industry-sponsored research open access.
Building trust with transparency: the importance of financial disclosures in medical publishing
Find out why financial relationships are not always correctly disclosed and how better transparency could be achieved.
Are researchers able to access trial data? Audit provides insights on data sharing from industry-sponsored studies
A recent study published in BMC Medicine audits data sharing from pharmaceutical industry-sponsored clinical studies.
Shire adopts a mandatory open access publishing policy
As the drive towards open access continues, pharmaceutical company Shire announced a new policy of mandatory open access publication of company-sponsored research.